Multidrug resistance is considered the most important limiting factor in cancer chemotherapy; therefore, inhibiting P-glycoprotein-mediated (P-gp) efflux and inhibiting agent development could be of great interest in cancer drug delivery systems research. This evidence concerns the gene PGP and cancer.